Opportunities to become the Go-To Provider for Pioneering Induced
Proximity Drug Developers Striving to Address Unmet Patient Need?
As the proximity phenomenon continued to bloom, new and distinguished biopharma geared up their efforts to develop new stabilization, modulation, post-translational modification, and inactivation/activation modalities with distinct mechanisms of action for unmet patient needs. To achieve this, they needed support in computational technologies, screening platforms, assay development, protein analysis, chemical biology and pre-clinical services and solutions.
The 4th Annual Induced Proximity-Based Drug Discovery Summit served as an outstanding opportunity to showcase your expertise and benchmark your brand as a key solutions provider and thought leader through our commercial partnership packages.
Benefit From Market Intelligence: Hear how and where biopharma are searching for services and solutions to facilitate their efforts to identify, validate and develop novel induced proximity small molecules and biologics
Showcase your World-Class Solutions: Differentiate your discovery and pre-clinical services from other solution providers to leverage your business from competitors
Generate Commercial Collaborations: Meet prospective clients during structured networking breaks, bespoke meetings and more informal networking receptions
Who Could You Have Met?
If you offer relevant services and would like to leverage your company within the induced proximity space, contact us to discuss a future, bespoke commercial package for next year's Induced Proximity-Based Drug Discovery Summit
For more information, email sponsor@hansonwade.com or download the full event guide here.
